• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 14-18, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 14-18, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/15/11Washington, DCN/AN/AParticipation in Research!America’s 2011 National Forum
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/18/11Washington, DCEd Cox, Luciana Borio, Wanda Russ by telephoneInfectious Diseases Society of America Board MembersAntimicrobial Resistance and Antibiotic Drug Development
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs3/14/11Washington, DCSeveral FDA officials and staff membersSeveral representatives from Private Industry and GovernmentKeynote address at the Pew Charitable Trusts Event
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs3/14/11-3/15/11Athens, GAMalcolm Frazier, Rick Friedman, Bill Frankos, Gregg Claycamp, Beverly Corey, Gary Buehler, Kim Rice (Retired), Evelyn Bonnin, Barbara Wood, Ed Rivera, Ileana Pettit, Phil CampbellPeter Barton Hutt (Covington and Burling); Dale Carter (Huber, Inc.); Robert Hoyt (University of Georgia); Ron Tetzlaff (PAREXEL); Heidi Davidson (Athens Mayor); Martin VanTrieste (Amegen); Cynthia Culmo, Zena Kaufman, Ballard Graham (Abbott Labs); Scott Bass (Sidney Austin, LLP); Doc Eldridge (Athens Chamber of Commerce); Maria Guazzaroni, Leslie Bloom (Pfizer); Tor Graberg (Sweden Medical Products Agency); Sabina Kopp (WHO); Charles Gummil, Bruce Little, Robert Scales (Health Canada)34th International Good Manufacturing Practices Conference:  GMPs-Spotlighting RISK Management
Curtis L. Coy, Deputy Commissioner for Administration3/14/11-3/18/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/16/11Washington, DCN/AAmerican Association for Cancer Reseach MembersTobacco Addiction, Disease and the New Law:  Implementation of the Family Smoking Prevention and Tobacco Control Act
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget3/14/11-3/18/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/17/11TeleconferenceMerton Smith, Michael Oehlsen, William Flynn, Jon Scheid, Meg Oeller, Steve Vaughn, Bettye Walters, Dan McChesney, Kevin Greenlees, William FlynnDavid Mackay, Kornielia Grein, Barbara Cyrus, Isaura Duarte, Jill Kieffer, Melanie Lievers, Georgia Sigala (European Medicines Agency)Quarterly Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/14/11Washington, DCSeveral FDA Officials and Staff MembersSeveral representatives from Private Industry, Government, and AcademiaInstitute of Medicine, Forum on Microbial Threats
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/15/11Washington, DCN/ASeveral representatives from Private Industry, Government, and AcademiaMcKinsey & Co. Summit on Private Sector Productivity
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition3/14/11-3/18/11N/AN/AN/ANo Significant Meetings 
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs3/14/11-3/18/11N/AN/AN/ANo Significant Meetings 
Beth Martino, Associate Commissioner for External Affairs3/17/11Silver Spring, MDN/ABill Beaman (OnPoint Strategies, Inc.)Communications Messaging
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research3/14/11-3/18/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/16/11Silver Spring, MDSeveral FDA officials and staff membersSeveral representatives from Sharps CoalitionMedical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/18/11Silver Spring, MDN/AWilliam Hawkins (Medtronics)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/15/11Jefferson, ARTom Flammang, Paul Howard, Merle Paule, Syed Ali, Serguei Liachenko, Donna Mendrick, Weida TongCathie Smith, Herb Bresler, April Brys, John Menkedick, Brian Roche (Battelle); Scott Retterer (Oak Ridge National Laboratory); David Schlyer (Brookhaven National Laboratory); Brian Thrall (Pacific Northwest National Laboratory); Ken Turteltaub (Lawrence Livermore National Laboratory)Multi-Scale Toxicology Initiative
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/7/11-3/11/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel3/17/11Silver Spring, MDNathan Brown, Seth Ray, Ann Witt, Thomas AbramsAlan Bennett (Ropes & Gray LLP); Coleen Klasmeier (Sidley Austin LLP)Medical Information Working Group (MIWG)
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/14/11-3/18/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/18/11Washington, DCLisa Rovin, Vicki Seyfert-MargolisMark McClellan (Engelberg Center for Health Care Reform at Brookings);  Amy Patterson (National Institute of Health)Reagan-Udall Foundation Board of Directors Meeting